These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 12230667)

  • 1. Helicobacter pylori infection.
    Delaney B; Moayyedi P; Forman D
    Clin Evid; 2002 Jun; (7):414-28. PubMed ID: 12230667
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter pylori infection.
    Delaney B; Moayyedi P; Forman D
    Clin Evid; 2002 Dec; (8):453-68. PubMed ID: 12603894
    [No Abstract]   [Full Text] [Related]  

  • 3. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN
    East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
    [No Abstract]   [Full Text] [Related]  

  • 4. Eradication of Helicobacter pylori and non-ulcer dyspepsia.
    Danesh J; Pounder RE
    Lancet; 2000 Mar; 355(9206):766-7. PubMed ID: 10711918
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ecabet sodium].
    Takahashi S; Tanaka A
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():711-6. PubMed ID: 11979876
    [No Abstract]   [Full Text] [Related]  

  • 6. [New S3 guideline of DGVS for eradication of Helicobacter pylori--recommendations for routine general practice. Focus on the stomach bacterium].
    MMW Fortschr Med; 2009 May; 151(22):48-9. PubMed ID: 19526970
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leaving Helicobacter pylori no chance. Triple therapy should consider resistance status].
    MMW Fortschr Med; 2005 May; 147(20):52. PubMed ID: 15957863
    [No Abstract]   [Full Text] [Related]  

  • 10. [Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients].
    Søndergaard B; Bytzer P
    Ugeskr Laeger; 2005 Jan; 167(5):500-2. PubMed ID: 15745170
    [No Abstract]   [Full Text] [Related]  

  • 11. [The drug prophylaxis of peptic ulcer exacerbations].
    Grigor'ev PIa; Iakovenko EP; Agafonova NA; Prianishnikova AS; Soluianova IP; Iakovenko AV; Vasil'ev IV; Agrba VZ; Stepanov AV; Kolodkin AM
    Ter Arkh; 1995; 67(2):26-9. PubMed ID: 7725253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
    Gasbarrini G; Malfertheiner P; Deltenre M; Mégraud F; O'Morain C; Pajares-García J; Quina M; Bianchi Porro G; Gasbarrini A; Franceschi F; Armuzzi A; Cammarota G; Anti M; Pretolani S
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S244-7. PubMed ID: 10077746
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of maintenance therapy by H2RA on the recurrence of gastric and duodenal ulcer and on the occurrence of reflux esophagitis, gastric erosions, and duodenal erosions after H. pylori eradication].
    Maeyama S; Yoshihara H; Kamada T; Kubota S; Kobayashi I; Tsuji S; Kawano S
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():512-5. PubMed ID: 16363591
    [No Abstract]   [Full Text] [Related]  

  • 14. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
    López-Brea M; Alarcón T
    Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tolerance and safety of anti-Helicobacter drugs in the treatment of ulcer disease].
    Artamonov VE; Masharova AA; Gorodetskiĭ VV; Vertkin AL
    Klin Med (Mosk); 2001; 79(2):53-7. PubMed ID: 11419089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is a 1-week treatment enough and safe for the healing of peptic ulcer?].
    Pajares JM; Gisbert JP
    Rev Esp Enferm Dig; 2000 Jan; 92(1):1-4. PubMed ID: 10758728
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrophic gastritis and Helicobacter pylori in reflux esophagitis.
    Repucci AH
    N Engl J Med; 1996 Sep; 335(10):750-1. PubMed ID: 8786770
    [No Abstract]   [Full Text] [Related]  

  • 20. [Short-term intervention in ulcer and reflux. New acid blocker halves duration of therapy].
    Einecke D
    MMW Fortschr Med; 2000 Jul; 142(26-27):50-1. PubMed ID: 10929487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.